A team has conducted a trial on the efficacy and safety of L-arginine in treating spinocerebellar ataxia type 6 (SCA6).

double-blind trial on the efficacy and safety of L-arginine in treating Spinocerebellar ataxia type 6 (SCA6). Spinocerebellar ataxia (SCA) is a neurodegenerative disorder affecting the cerebellum ...

This Japanese study enrolled 8 patients with the cerebellar variant of multiple system atrophy (MSA-C), 7 patients with spinocerebellar ataxia type ... ataxia type 6 (SCA6), and 13 healthy controls.

double-blind trial on the efficacy and safety of L-arginine in treating Spinocerebellar ataxia type 6 (SCA6). I. Background of the Study Spinocerebellar ataxia (SCA) is a neurodegenerative ...

A team has conducted a trial on the efficacy and safety of L-arginine in treating spinocerebellar ataxia type 6 (SCA6). The findings are published in the journal eClinicalMedicine, and the team ...

double-blind study to assess the effectiveness and safety of L-arginine in treating Spinocerebellar ataxia type 6 (SCA6) (1 Trusted Source New Drug Candidate for Spinocerebellar Ataxia ...